NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
89,436,431
Share change
-322,366
Total reported value
$8,572,935,331
Put/Call ratio
242%
Price per share
$95.85
Number of holders
394
Value change
-$29,252,870
Number of buys
186
Number of sells
219

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2020

As of 31 Dec 2020, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 394 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 89,436,431 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, Bellevue Group AG, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 394 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.